NASDAQ:BYSI - BeyondSpring Inc.
$17.77
 $0.00
0.00%
2:35PM EDT
2019-02-15
BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase II/III clinical trial for the prevention of non-docetaxel chemotherapy-induced severe, grade 4 neutropenia, and a Phase III clinical trial as an anticancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). Plinabulin has also entered in a Phase I/II clinical trials to investigate its therapeutic potential in combination with the immuno-oncology agent nivolumab.The Company's product, Plinabulin, is a marine derived small-molecule with a range of biological activities. Plinabulin targets cells in the tumor vasculature resulting in selective anti-tumor activity. Plinabulin has also demonstrated a range of immuno-stimulatory effects, including stimulating the maturation of dendritic cells, increasing cytokine secretion, down regulating inhibitory T-cells, and stimulating tumor-antigen-specific T-cell activation. The Company's BPI-002 program is based on an oral small molecule agent, which induces T-cell activation. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BYSI     avg for
industry  
  avg for
sector  
42 stocks weight:  28. 02   0. 00   0. 00  
42 stocks rank:  3. 39 K 1. 86 K 1. 09 K
# analyst opinions:  3. 00   14. 92   14. 43  

quick ratio:  3. 95   5. 37   1. 81  
current ratio:  4. 36   5. 69   2. 19  

target price low:  19. 10   88. 97   117. 82  
target price avg:  35. 00   115. 19   141. 96  
target price high:  49. 50   143. 40   163. 16  
1-yr high:  33. 33   124. 30   142. 77  
last close:  18. 13   101. 85   127. 84  
50-day avg:  19. 38   98. 27   122. 46  
200-day avg:  23. 14   99. 72   122. 70  
1-yr low:  17. 15   78. 19   100. 16  
volume:  1. 01 K 2. 38 M 4. 64 M
50-day avg volume:  4. 26 K 3. 31 M 4. 94 M
200-day avg volume:  6. 74 K 3. 23 M 4. 28 M

1-day return:  0. 17 % 0. 22 % 0. 48 %
this week return:  -9. 17 % 1. 77 % 2. 01 %
12-wk return:  -27. 04 % 6. 56 % 3. 33 %
52-wk return:  -30. 81 % -2. 23 % 14. 35 %

enterprise value (EV):  395. 81 M 55. 17 B 104. 51 B
market cap:  426. 77 M 49. 01 B 96. 46 B
EBITDA:  -62. 31 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -6. 35   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -56. 85 M 2. 37 B 3. 58 B

shares outstanding:  23. 17 M 607. 99 M 1. 22 B
shares:  4. 36 M 605. 53 M 1. 15 B
shares short:  229. 13 K 11. 62 M 12. 55 M
shares short prior month:  223. 20 K 11. 95 M 13. 44 M
short ratio:  49. 99   4. 82   3. 10  
short % of float:  2. 89 % 6. 19 % 2. 82 %
total cash/share:  0. 97   12. 02   11. 46  
total cash:  22. 43 M 7. 41 B 7. 37 B
free cash flow:  -17. 92 M 95. 99 M 2. 04 B
operating cash flow:  -40. 43 M 164. 74 M 3. 04 B

book value:  0. 86   14. 43   28. 26  
price/book:  21. 16   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  24. 88 % --- ---
1-yr mean volatility:  -0. 10 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 58   3. 03   4. 09  
forward EPS:  -1. 69   4. 33   6. 99  
P/E:  -7. 04   6. 11   26. 91  
forward P/E:  -11. 81   8. 38   10. 48  
PE/G:  2. 74   0. 37   5. 61  
growth:  -2. 57 % 683. 72 % 104. 79 %
earnings high:  -0. 54   1. 27   1. 66  
earnings avg:  -0. 56   1. 01   1. 53  
earnings low:  -0. 58   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -101. 72 % -3. 27 % 3. 81 %
return on equity:  -179. 19 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  0. 07   1. 21   0. 93  
sharpe (1yr):  -0. 39   0. 06   0. 98  

held % insiders:  146. 36 % 6. 46 % 3. 21 %
held % institutions:  1. 37 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : BYSI
.    + 1.683 =         1.683 :: INITIAL WEIGHT
.  + 366.182 =       367.865 :: inverse volume-to-price addition
.  + 423.067 =       790.932 :: spline projection addition
.  - 131.456 =       659.476 :: poor performance penalty
.    x 0.803 =       529.485 :: one-year gains+dividend factor
.     x 3.02 =      1598.963 :: 13 weeks' performance factor
.    x 1.492 =      2386.435 :: industry recommendation factor
.     x 0.99 =       2362.16 :: return on assets factor
.    x 0.982 =      2319.833 :: return on equity factor
.    x 2.766 =      6416.955 :: current ratio factor
.    x 1.157 =        7426.3 :: quick ratio factor
.     x 1.01 =       7500.21 :: short ratio factor
.    x 2.374 =     17806.422 :: price-to-book factor
.     x 2.13 =     37933.868 :: P/E weight
.    x 0.777 =     29473.738 :: PE/G factor
.    x 1.435 =     42287.982 :: beta factor
.    x 0.394 =     16651.122 :: sharpe factor
.     x 1.23 =     20483.032 :: target low factor
.    x 1.322 =     27069.182 :: target mean factor
.    x 1.132 =     30629.866 :: target high factor
.    x 1.066 =     32639.578 :: industry 12-weeks return
.    x 0.918 =     29962.714 :: "drift" penalty 1 days ago
.     x 0.89 =     26658.051 :: "drift" penalty 2 days ago
.    x 0.991 =     26415.133 :: overall "drift" factor
.    x 0.751 =     19842.065 :: largest single-day jump factor
.     x 1.01 =     20040.284 :: mean volatility factor
.    x 1.098 =     22000.944 :: 42-day mean volatility factor
.      x 1.0 =     22002.421 :: factor hist industry gain for week 06
.   cubeRoot =        28.021 :: reduced for readability
.                     28.021 :: FINAL WEIGHT for NASDAQ:BYSI


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org